Shensong Yangxin Capsule prevents diabetic myocardial fibrosis by inhibiting TGF-β1/Smad signaling
Author:
Funder
National Natural Science Foundation of China
National Basic Research Program of China
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference40 articles.
1. Development of Wistar rat model of insulin resistance;Ai;World Journal of Gastroenterology,2005
2. The protective effect of Daming capsule on heart function in streptozocin-induced diabetic rats with hyperlipidemia;Ai;Biological & Pharmaceutical Bulletin,2009
3. Myocardial fibrosis and apoptosis, but not inflammation, are present in long-term experimental diabetes;Ares-Carrasco;American Journal of Physiology – Heart and Circulatory Physiology,2009
4. Diabetic cardiomyopathy revisited;Boudina;Circulation,2007
5. Increase of myocardial performance by Rhodiola–ethanol extract in diabetic rats;Cheng;Journal of Ethnopharmacology,2012
Cited by 75 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Atrial tachyarrhythmia prevention by Shensong Yangxin after catheter ablation for persistent atrial fibrillation: the SS-AFRF trial;European Heart Journal;2024-08-23
2. Shensong yangxin, a multi-functional traditional Chinese medicine for arrhythmia: A review of components, pharmacological mechanisms, and clinical applications;Heliyon;2024-08
3. The signaling pathways of selected traditional Chinese medicine prescriptions and their metabolites in the treatment of diabetic cardiomyopathy: a review;Frontiers in Pharmacology;2024-07-03
4. Spinosin inhibits activated hepatic stellate cell to attenuate liver fibrosis by targeting Nur77/ASK1/p38 MAPK signaling pathway;European Journal of Pharmacology;2024-03
5. Exercise alleviates renal interstitial fibrosis by ameliorating the Sirt1-mediated TGF-β1/Smad3 pathway in T2DM mice;Endocrine Connections;2024-01-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3